Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value has taken a roughly $1 billion stake in the drug maker and is pushing for changes. Monitor ...

Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating yesterday. David Risinger has ...

(Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

has been a mixed bag for energy stocks, with economic concerns, geopolitical risk and volatile oil prices, but some oil and gas stocks have outperformed the rest of the market.

Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...

This article explores the disconnect between expert opinions and voter sentiment on economic policies, highlighting the ...

Ultragenyx Pharmaceutical said Monday that it has received breakthrough therapy designation from the Food and Drug Administration for its treatment to reduce the risk of fracture associated with ...

Starboard Value, an activist investment firm, has taken a significant $1 billion stake in Pfizer, signaling its intent to ...

The Dow plunged nearly 400 points on Monday while Treasury yields rose, as traders tamped down bets for Federal Reserve ...

An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories.